Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

Abstract

An association between raised renin levels and myocardial infarction has been reported. We studied the effects of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, on the development of myocardial infarction and unstable angina in 6797 patients with ejection fractions Patients were randomly assigned to placebo (n=3401) or enalapril (n=3396) at doses of 2[middle dot]5-20 mg per day in two concurrent double-blind trials with the same protocol. Patients with heart failure entered the treatment trial (n=2569) and those without heart failure entered the prevention trial (n=4228). Follow-up averaged 40 months. In each trial there were significant reductions in the number of patients developing myocardial infarction (treatment trial: 158 placebo vs 127 enalapril, PEnalapril treatment significantly reduced myocardial infarction, unstable angina, and cardiac mortality in patients with low ejection fractions.